Status | Study |
Not yet recruiting |
Study Name: Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy Condition: Soft Tissue Sarcoma, Adult, Stage II Date: 2017-04-17 Interventions: Drug: Apatinib Apatinib 500 mg is administered orally daily, until disease progression or untolerable to |
Not yet recruiting |
Study Name: Use of Propranolol Hydrochloride in the Treatment of Metastatic STS Condition: Malignant Soft Tissue Sarcoma Date: 2017-03-16 Interventions: Drug: Propranolol Hydrochloride |
Not yet recruiting |
Study Name: A Phase II Study of Apatinib in STS Patients Condition: Soft Tissue Sarcoma Date: 2017-02-22 Interventions: Drug: apatinib apatinib 500mg po. qd. Other Name: ap |
Not yet recruiting |
Study Name: Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas Condition: Soft Tissue Sarcoma Date: 2017-02-01 Interventions: Drug: Selinexor Selinexor is a |
Recruiting |
Study Name: Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS) Condition: Advanced Soft-tissue Sarcoma Metastatic Soft-tissue Sarcoma Date: 2017-01-13 Interventions: Other: No Intervention This is a NIS. No intervention. |
Not yet recruiting |
Study Name: Trabectedin Maintenance Post 1st-line in STS Condition: Sarcoma, Soft Tissue Date: 2016-10-07 Interventions: Drug: Trabectedin Trabectedin 1.2 mg/m² through a central venous catheter as an IV infusion over 24 |
Not yet recruiting |
Study Name: Ph II Nintedanib or Intravenous Ifosfamide Advanced Metastatic STS Failed on Imatinib and Sunitinib Condition: Sarcoma, Soft Tissue Date: 2016-06-17 Interventions: Drug: Nintedanib Pharmaceutica |
Recruiting |
Study Name: Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas Condition: Alveolar Soft Part Sarcoma Soft Tissue Sarcomas Date: 2015-12-14 Interventions: Drug: Axitinib Twice daily dos |
Recruiting |
Study Name: Preoperative vs Postoperative IMRT for Extremity/Truncal STS Condition: Adult Soft Tissue Sarcoma Date: 2015-09-18 Interventions: Radiation: Preoperative intensity modulated radiation therapy |
Active, not recruiting |
Study Name: Study of Anlotinib in Patients With Soft Tissue Sarcoma(STS)(ALTER0203) Condition: Soft Tissue Sarcoma Date: 2015-05-17 Interventions: Drug: Anlotinib Anlotinib p.o. |